Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.
about
Advances in Diagnosis and Treatments for Immune ThrombocytopeniaImmune thrombocytopeniaPositioning new treatments in the management of immune thrombocytopeniaB cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonistsHigh response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.Immune thrombocytopenia: recent progress in pathophysiology and treatment.A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.Rituximab leads to long remissions in patients with chronic immune thrombocytopeniaThe Effect of Danazol in Primary Immune Thrombocytopenia: An Analysis of a Large Cohort From a Single Center in China.Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles.How we manage immune thrombocytopenia in the elderly.Factors associated with the effect of open splenectomy for immune thrombocytopenic purpura.Combination therapy in relapsed or refractory chronic immune thrombocytopenia: a case report and literature review.B-cell targeted therapeutics in clinical development.Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness.Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura.Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.
P2860
Q26738630-7B70FED5-2C7F-4671-BC3B-64BE3BBD2E46Q26830918-551595C8-150C-4882-B3ED-79A12D7927D7Q33404095-48752C7E-5AD7-4D72-B232-D622A9F6BEFAQ33404838-4EA6FDF5-CF74-450B-A33D-7F7AAFC6E450Q33406176-3E4494B6-EDB3-42E2-BFCC-8BDAAD6FD639Q33406310-808457C8-1981-4D89-9E54-B91039BB4ADBQ33408621-6A10EF8C-4550-4AED-91DD-77AFD5F6CDD7Q33410348-74A70485-A0AE-4BA0-931C-43C95D9EE7C3Q33413896-888DAC38-C925-4CA1-A0E4-1A47C1B74E5AQ33416569-91809D1B-0D53-4C89-9991-C568C677A4CAQ33416947-899BFC35-3BDD-4EBC-BDC8-824CE484FC2AQ33422731-55868299-DFE3-4453-97E3-F78622A12841Q33428522-0E93D0D9-75BC-441C-AD08-A37BB15D802DQ33431198-D4007C9D-76A0-4699-B1A7-E0B200505D48Q33431371-E181495D-D5CA-4CAF-BBDB-BB4D9A6F5F86Q33432631-F89AE687-CC26-480F-BDD1-0DED4ADBEE63Q33433705-AC7F6DAC-F234-4CB6-854B-03DA17153A63Q38097162-F1771389-25E5-403D-BCAE-A38DB6B7170CQ38215451-0E607D60-A86C-415D-AA92-BB714659646CQ40040235-FCC0F1E3-748C-417F-914C-3F91639AB5F0Q42694850-9702D291-AD95-4877-A95B-0AE00E3252B6
P2860
Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rituximab before splenectomy i ...... enic purpura: a meta-analysis.
@ast
Rituximab before splenectomy i ...... enic purpura: a meta-analysis.
@en
type
label
Rituximab before splenectomy i ...... enic purpura: a meta-analysis.
@ast
Rituximab before splenectomy i ...... enic purpura: a meta-analysis.
@en
prefLabel
Rituximab before splenectomy i ...... enic purpura: a meta-analysis.
@ast
Rituximab before splenectomy i ...... enic purpura: a meta-analysis.
@en
P2093
P2860
P1476
Rituximab before splenectomy i ...... enic purpura: a meta-analysis.
@en
P2093
Jean François Rossi
Philippe Quittet
Sophie Auger
Yohan Duny
P2860
P304
P356
10.1111/J.1365-2141.2012.09169.X
P407
P577
2012-05-22T00:00:00Z